{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T19:27:37Z","timestamp":1794338857358,"version":"4.9.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"36","license":[{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Novartis Pharma Research Grants"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>This study evaluated the prognosis and prognostic factors of patients with cardiac sarcoidosis (CS), an underdiagnosed disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Patients from a retrospective multicentre registry, diagnosed with CS between 2001 and 2017 based on the 2016 Japanese Circulation Society or 2014 Heart Rhythm Society criteria, were included. The primary endpoint was a composite of all-cause death, hospitalization for heart failure, and documented fatal ventricular arrhythmia events (FVAE), each constituting exploratory endpoints. Among 512 registered patients, 148 combined events (56 heart failure hospitalizations, 99 documented FVAE, and 49 all-cause deaths) were observed during a median follow-up of 1042 (interquartile range: 518\u20131917) days. The 10-year estimated event rates for the primary endpoint, all-cause death, heart failure hospitalizations, and FVAE were 48.1, 18.0, 21.1, and 31.9%, respectively. On multivariable Cox regression, a history of ventricular tachycardia (VT) or fibrillation [hazard ratio (HR) 2.53, 95% confidence interval (CI) 1.59\u20134.00, P\u2009&amp;lt;\u20090.001], log-transformed brain natriuretic peptide (BNP) levels (HR 1.28, 95% CI 1.07\u20131.53, P\u2009=\u20090.008), left ventricular ejection fraction (LVEF) (HR 0.94 per 5% increase, 95% CI 0.88\u20131.00, P\u2009=\u20090.046), and post-diagnosis radiofrequency ablation for VT (HR 2.65, 95% CI 1.02\u20136.86, P\u2009=\u20090.045) independently predicted the primary endpoint.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Although mortality is relatively low in CS, adverse events are common, mainly due to FVAE. Patients with low LVEF, with high BNP levels, with VT\/fibrillation history, and requiring ablation to treat VT are at high risk.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurheartj\/ehac323","type":"journal-article","created":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T21:06:50Z","timestamp":1656882410000},"page":"3450-3459","source":"Crossref","is-referenced-by-count":92,"title":["Risk stratification of patients with cardiac sarcoidosis: the ILLUMINATE-CS registry"],"prefix":"10.1093","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4671-7667","authenticated-orcid":false,"given":"Takeru","family":"Nabeta","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Kitasato University School of Medicine , Sagamihara , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2416-5865","authenticated-orcid":false,"given":"Takeshi","family":"Kitai","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center , Suita , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9630-951X","authenticated-orcid":false,"given":"Yoshihisa","family":"Naruse","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine , Hamamatsu , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsunori","family":"Taniguchi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine , Suita , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Yoshioka","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kameda Medical Center , Chiba , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1642-7039","authenticated-orcid":false,"given":"Hidekazu","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine , Kobe , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5076-2052","authenticated-orcid":false,"given":"Takahiro","family":"Okumura","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine , Nagoya , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuntaro","family":"Sato","sequence":"additional","affiliation":[{"name":"Clinical Research Canter, Nagasaki University Hospital , Nagasaki , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2616-0443","authenticated-orcid":false,"given":"Yuichi","family":"Baba","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University , Kochi , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3464-6016","authenticated-orcid":false,"given":"Keisuke","family":"Kida","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, St Marianna University School of Medicine , Kawasaki , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0217-6598","authenticated-orcid":false,"given":"Yodo","family":"Tamaki","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tenri Hospital , Nara , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Toho University Faculty of Medicine , Tokyo , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2456-8525","authenticated-orcid":false,"given":"Yuya","family":"Matsue","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine , 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421 , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,6,29]]},"reference":[{"key":"2022092120400045600_ehac323-B1","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1253\/circj.CJ-19-0508","article-title":"JCS 2016 Guideline on diagnosis and treatment of cardiac sarcoidosis\u2015digest version","volume":"83","author":"Terasaki","year":"2019","journal-title":"Circ J"},{"key":"2022092120400045600_ehac323-B2","first-page":"19","article-title":"The WASOG sarcoidosis organ assessment instrument: an update of a previous clinical tool","volume":"31","author":"Judson","year":"2014","journal-title":"Sarcoidosis Vasc Diffus Lung Dis"},{"key":"2022092120400045600_ehac323-B3","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/j.jacc.2020.08.042","article-title":"Challenges in cardiac and pulmonary sarcoidosis: JACC state-of-the-art review","volume":"76","author":"Trivieri","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2022092120400045600_ehac323-B4","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1056\/NEJMra071714","article-title":"Sarcoidosis","volume":"357","author":"Iannuzzi","year":"2007","journal-title":"N Engl J Med"},{"key":"2022092120400045600_ehac323-B5","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/ehjci\/ehaa946.0325","article-title":"Diagnostic performance of advanced cardiac imaging for detection of cardiac sarcoidosis: a systematic review and meta-analysis","volume":"41","author":"Ballo","year":"2020","journal-title":"Eur Heart J"},{"key":"2022092120400045600_ehac323-B6","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1161\/CIRCULATIONAHA.109.851352","article-title":"Detection of myocardial damage in patients with sarcoidosis","volume":"120","author":"Kim","year":"2009","journal-title":"Circulation"},{"key":"2022092120400045600_ehac323-B7","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/eurjhf\/hfr099","article-title":"Myocardial damage in patients with sarcoidosis and preserved left ventricular systolic function: an observational study","volume":"13","author":"Patel","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"2022092120400045600_ehac323-B8","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS Expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"key":"2022092120400045600_ehac323-B9","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1007\/s00259-013-2460-5","article-title":"Elevated 18F-fluorodeoxyglucose uptake in the interventricular septum is associated with atrioventricular block in patients with suspected cardiac involvement sarcoidosis","volume":"40","author":"Manabe","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2022092120400045600_ehac323-B10","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1093\/eurheartj\/ehab724.2763","article-title":"Clinical phenotypes of cardiac sarcoidosis by latent class analysis","volume":"42","author":"Dai","year":"2021","journal-title":"Eur Heart J"},{"key":"2022092120400045600_ehac323-B11","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.011522","article-title":"Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study","volume":"131","author":"Kandolin","year":"2015","journal-title":"Circulation"},{"key":"2022092120400045600_ehac323-B12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.chest.2016.08.1457","article-title":"Cardiac sarcoidosis: the impact of age and implanted devices on survival","volume":"151","author":"Zhou","year":"2017","journal-title":"Chest"},{"key":"2022092120400045600_ehac323-B13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ahj.2008.09.009","article-title":"Cardiac sarcoidosis","volume":"157","author":"Kim","year":"2009","journal-title":"Am Heart J"},{"key":"2022092120400045600_ehac323-B14","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0002-9149(01)01978-6","article-title":"Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone","volume":"88","author":"Yazaki","year":"2001","journal-title":"Am J Cardiol"},{"key":"2022092120400045600_ehac323-B15","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0735-1097(02)02715-8","article-title":"A clinical and histopathologic comparison of cardiac sarcoidosis and idiopathic giant cell myocarditis","volume":"41","author":"Okura","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2022092120400045600_ehac323-B16","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1253\/circj.CJ-14-1275","article-title":"Effect of corticosteroid therapy on long-term clinical outcome and left ventricular function in patients with cardiac sarcoidosis","volume":"79","author":"Nagai","year":"2015","journal-title":"Circ J"},{"key":"2022092120400045600_ehac323-B17","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.amjcard.2004.08.083","article-title":"Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis","volume":"95","author":"Chiu","year":"2005","journal-title":"Am J Cardiol"},{"key":"2022092120400045600_ehac323-B18","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/01.CIR.58.6.1204","article-title":"Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis","volume":"58","author":"Silverman","year":"1978","journal-title":"Circulation"},{"key":"2022092120400045600_ehac323-B19","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/hc0402.102975","article-title":"A statement for healthcare professionals from the cardiac imaging committee of the council on clinical cardiology of the American heart association","volume":"105","author":"Cerqueira","year":"2002","journal-title":"Circulation"},{"key":"2022092120400045600_ehac323-B20","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/ejhf.2018","article-title":"Standardized definitions for evaluation of heart failure therapies: scientific expert panel from the heart failure collaboratory and academic research consortium","volume":"22","author":"Abraham","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2022092120400045600_ehac323-B21","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1161\/CIRCOUTCOMES.109.875658","article-title":"Missing data analysis using multiple imputation: getting to the heart of the matter","volume":"3","author":"He","year":"2010","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2022092120400045600_ehac323-B22","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/biomet\/86.4.948","article-title":"Small-sample degrees of freedom with multiple imputation","volume":"86","author":"Barnard","year":"1999","journal-title":"Biometrika"},{"key":"2022092120400045600_ehac323-B23","doi-asserted-by":"crossref","first-page":"e007488","DOI":"10.1161\/CIRCEP.119.007488","article-title":"Assessment of the 2017 AHA\/ACC\/HRS guideline recommendations for implantable cardioverter-defibrillator implantation in cardiac sarcoidosis","volume":"12","author":"Kazmirczak","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2022092120400045600_ehac323-B24","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1161\/CIRCEP.113.000156","article-title":"Magnetic resonance imaging for identifying patients with cardiac sarcoidosis and preserved or mildly reduced left ventricular function at risk of ventricular arrhythmias","volume":"7","author":"Crawford","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2022092120400045600_ehac323-B25","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","article-title":"Index for rating diagnostic tests","volume":"3","author":"Youden","year":"1950","journal-title":"Cancer"},{"key":"2022092120400045600_ehac323-B26","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.hrthm.2015.06.032","article-title":"Comparison of cardiac MRI and 18F-FDG positron emission tomography manifestations and regional response to corticosteroid therapy in newly diagnosed cardiac sarcoidosis with complete heart block","volume":"12","author":"Orii","year":"2015","journal-title":"Heart Rhythm"},{"key":"2022092120400045600_ehac323-B27","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.amjcard.2009.03.068","article-title":"Comparison of necropsy findings in patients with sarcoidosis dying suddenly from cardiac sarcoidosis versus dying suddenly from other causes","volume":"104","author":"Tavora","year":"2009","journal-title":"Am J Cardiol"},{"key":"2022092120400045600_ehac323-B28","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1093\/eurheartj\/ehz428","article-title":"Sudden death in cardiac sarcoidosis: an analysis of nationwide clinical and cause-of-death registries","volume":"40","author":"Ekstr\u00f6m","year":"2019","journal-title":"Eur Heart J"},{"key":"2022092120400045600_ehac323-B29","doi-asserted-by":"crossref","first-page":"e0238391","DOI":"10.1371\/journal.pone.0238391","article-title":"Cardiac sarcoidosis: a long term follow up study","volume":"15","author":"Cacoub","year":"2020","journal-title":"PLoS One"},{"key":"2022092120400045600_ehac323-B30","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1513\/AnnalsATS.201511-760OC","article-title":"Sarcoidosis in America. Analysis based on health care use","volume":"13","author":"Baughman","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"2022092120400045600_ehac323-B31","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1183\/13993003.00477-2016","article-title":"Sarcoidosis incidence and prevalence: a nationwide register-based assessment in Sweden","volume":"48","author":"Arkema","year":"2016","journal-title":"Eur Respir J"},{"key":"2022092120400045600_ehac323-B32","first-page":"1052","article-title":"Autoimmune big data study group. Geoepidemiological big data approach to sarcoidosis: geographical and ethnic determinants","volume":"37","author":"Brito-Zer\u00f3n","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"2022092120400045600_ehac323-B33","doi-asserted-by":"crossref","first-page":"e003353","DOI":"10.1161\/CIRCEP.115.003353","article-title":"Time course and factors correlating with ventricular tachyarrhythmias after Introduction of steroid therapy in cardiac sarcoidosis","volume":"9","author":"Segawa","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2022092120400045600_ehac323-B34","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/europace\/eus316","article-title":"Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis","volume":"15","author":"Kron","year":"2013","journal-title":"Europace"},{"key":"2022092120400045600_ehac323-B35","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.hrthm.2012.02.010","article-title":"Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators","volume":"9","author":"Betensky","year":"2012","journal-title":"Heart Rhythm"},{"key":"2022092120400045600_ehac323-B36","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.amjcard.2020.04.025","article-title":"Risk of adverse cardiovascular events in cardiac sarcoidosis independent of left ventricular function","volume":"127","author":"Rosenthal","year":"2020","journal-title":"Am J Cardiol"},{"key":"2022092120400045600_ehac323-B37","doi-asserted-by":"crossref","first-page":"e019415","DOI":"10.1161\/JAHA.120.019415","article-title":"Manifestations and outcome of cardiac sarcoidosis and idiopathic giant cell myocarditis by 25-year nationwide cohorts","volume":"10","author":"Nordenswan","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"2022092120400045600_ehac323-B38","first-page":"2663","article-title":"Cardiac manifestations of sarcoidosis: diagnosis and management","volume":"38","author":"Birnie","year":"2017","journal-title":"Eur Heart J"},{"key":"2022092120400045600_ehac323-B39","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.jacc.2020.06.038","article-title":"Long-term adverse cardiac outcomes in patients with sarcoidosis","volume":"76","author":"Yafasova A, Fosb\u00f8l EL, Schou M, Gustafsson F, Rossing K, Bundgaard H","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2022092120400045600_ehac323-B40","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1161\/CIRCULATIONAHA.105.608869","article-title":"B-type natriuretic peptide predicts adverse cardiovascular events in pediatric outpatients with chronic left ventricular systolic dysfunction","volume":"114","author":"Price","year":"2006","journal-title":"Circulation"},{"key":"2022092120400045600_ehac323-B41","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ijcard.2020.11.044","article-title":"Risk and predictors of sudden death in cardiac sarcoidosis: a systematic review and meta-analysis","volume":"328","author":"Franke","year":"2021","journal-title":"Int J Cardiol"},{"key":"2022092120400045600_ehac323-B42","doi-asserted-by":"crossref","first-page":"e006145","DOI":"10.1161\/CIRCEP.117.006145","article-title":"Outcome of cardiac sarcoidosis presenting with high-grade atrioventricular block","volume":"11","author":"Nordenswan","year":"2018","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2022092120400045600_ehac323-B43","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.cjca.2013.02.004","article-title":"Corticosteroid therapy for cardiac sarcoidosis: a systematic review","volume":"29","author":"Sadek","year":"2013","journal-title":"Can J Cardiol"},{"key":"2022092120400045600_ehac323-B44","first-page":"113","article-title":"Prognosis after pacemaker implantation in cardiac sarcoidosis in Japan. Clinical evaluation of corticosteroid therapy","volume":"11","author":"Takada","year":"1994","journal-title":"Sarcoidosis"},{"key":"2022092120400045600_ehac323-B45","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/europace\/eux077","article-title":"Catheter ablation for ventricular tachycardia in patients with cardiac sarcoidosis: a systematic review","volume":"20","author":"Papageorgiou","year":"2018","journal-title":"Europace"},{"key":"2022092120400045600_ehac323-B46","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.hrthm.2008.10.039","article-title":"Role of radiofrequency catheter ablation of ventricular tachycardia in cardiac sarcoidosis: report from a multicenter registry","volume":"6","author":"Jefic","year":"2009","journal-title":"Heart Rhythm"},{"key":"2022092120400045600_ehac323-B47","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1161\/CIRCEP.112.971341","article-title":"Catheter ablation of ventricular tachycardia in nonischemic heart disease","volume":"5","author":"Tokuda","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2022092120400045600_ehac323-B48","doi-asserted-by":"crossref","first-page":"e004333","DOI":"10.1161\/CIRCEP.116.004333","article-title":"Long-term outcomes of catheter ablation of ventricular tachycardia in patients with cardiac sarcoidosis","volume":"9","author":"Muser","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2022092120400045600_ehac323-B49","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1093\/europace\/euz332","article-title":"2019 HRS\/EHRA\/APHRS\/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias: executive summary","volume":"22","author":"Cronin","year":"2020","journal-title":"Europace"},{"key":"2022092120400045600_ehac323-B50","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ahj.2020.02.008","article-title":"Performance of diagnostic criteria in patients clinically judged to have cardiac sarcoidosis: is it time to regroup?","volume":"223","author":"Ribeiro Neto","year":"2020","journal-title":"Am Heart J"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/43\/36\/3450\/45955715\/ehac323.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/43\/36\/3450\/45955715\/ehac323.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T16:42:19Z","timestamp":1663778539000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/43\/36\/3450\/6619356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,29]]},"references-count":50,"journal-issue":{"issue":"36","published-online":{"date-parts":[[2022,6,29]]},"published-print":{"date-parts":[[2022,9,21]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehac323","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,9,21]]},"published":{"date-parts":[[2022,6,29]]}}}